Antimicrobial drugs prescribing in 34 French emergency department;Prescriptions d'antibiotiques dans 34 services d'accueil et de traitement des urgences Français

Medecine et Maladies Infectieuses

Volumn 33, Issue 2, 2003, Pages 70-77

  Elkharrat, D ^a   Brun Ney, D ^b   Cordier, B ^b   Goldstein, F ^b   Pean Y ^b   Sanson Le Pors, M J ^b   Viso, P M ^b   Zarka, M ^b   Debatisse, A ^b   Scheimberg, A ^b   Pecking, M ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

Antibiotics prescription; Emergency ward

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ISOPENICILLIN N; MACROLIDE; NALIDIXIC ACID; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; EAR NOSE THROAT DISEASE; EMERGENCY WARD; ESCHERICHIA COLI; FOLLOW UP; FRANCE; GASTROINTESTINAL INFECTION; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; INFECTION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; MORTALITY; PRESCRIPTION; PREVALENCE; PROTEUS MIRABILIS; RESPIRATORY TRACT INFECTION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION;

EID: 0037299611     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(02)00008-2     Document Type: Article

References (37)

1. Baron D, Dorak B, Touzé MD, Potel G. Étude prospective de la pathologie infectieuse dans les services d'urgences (SU). Abstract in Rean Soins intensifs Médecine d'Urgence 1990;6:519.
2. Talan DA. Infectious diseases issues in the emergency department. Clin Infect Dis 1996;23:1-14.
3. e Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse Paris, 7-12 Décembre 2000, 2000 Paris p. 121.
4. Fourestié V, Roussignol E, Elkharrat D, Ross A, Simon N. Classification clinique des malades des Urgences: définition et reproductibilité. Réan Urg 1994;3(5):573-8.
5. Fine MJ, Auble T, Yely DM, et al. Prediction rule to identify low risk patients with community-acquired pneumoniae. N Engl J Med 1997; 336:243-50.
6. Keim SM, Meislin HW. The appropriate utilization of miscellaneous cultures, in Cost-effectiveDiagnostic Testing in Emergency Medicine. American College of Emergency Physicians, Dallas, Texas, 1994 pp.85-88.
7. L'antibioprophylaxie en chirurgie. Recommandations de l'Andem. Concours Médical 1996;41(suppl.):29-44.
8. Simon N, Frey A, Rabault M, Ropital A. Evaluation d'une grille de critères d'hospitalisation des malades dans un service d'accueil. Réan Urg 1992:92.
9. Gupta K, Choles D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8.
10. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001;33: 89-94.
11. Huchon G, Chidiac C, Delaval P, Leophonte P, Bouton IY, Roche N, Trémolières F. Conduite à tenir devant une infection respiratoire basse communautaire de l'adulte. Recommandations de la Société de Pneumologie de Langue Française. Rev Mal Resp 1999;16:224-33.
12. Antibiothérapie par voie générale en pratique courante des infections ORL et respiratoires basses. Recommandations de bonne pratique de l'antibiothérapie en pratique courante de la SPILF. Med Mal Infect 1999;29:205-60.
13. e conférence de consensus en thérapeutique anti-infectieuse, antibiotiques des infections urinaires, société de pathologie infectieuse de langue française. Lettre de l'Infectiologue 1991;1:20-5.
14. Cystites et pyélonéphrites aiguës simples de la femme de 15 à 65 ans, en dehors de la grossesse. Recommandations et références médicales de l'Agence Nationale pour le Développement de l'Evaluation Médicale. Suppl au Concours Médical, 1996 p. 26-42.
15. Conférence de Consensus sur les érysipèles. Ann Dermatol Vénérol 2000;127:336-40.
16. Cunnings P, Del Beccaro MA. Antibiotics to prevent infection of simple wounds: a meta-analysis of randomized studies. Am J Emerg Med 1995;4:396-400.
17. Holzapfel L, Jacquet-Francillon T, Rahmani J, et al. Microbiological evaluation of infected wounds of the extremities in 214 adults. J Accid Emerg Med 1999;1:32-4.
18. Guillemot D, Carbon C, Vauzelle-Kervroëdan F, Balkau B, Maison P, Bouvenot G, Eschwège E. Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998;51:61-8.
19. Guillemot D, Maison P, Carbon C, Balkau B, Vauzelle-Kervroëdan F, Sermet C, Bouvenot G, Eschwège E. Trends in antimicrobial drug use in the community-France, 1981-1992. J Infect Dis 1998;177:492-7.
20. Thuong M, Schortgen F, Zazempa V, Giron E, Soussy CJ, BrunBuisson C. Appropriate use of restricted antimicrobial agents in hospital: the importance of empirical therapy and assisted reevaluation. J Antimicrob Chemotherapy 2000;46:501-8.
21. Agence du médicament. Prescription et consommation des antibiotiques en ambulatoire. Presse Méd 1999;28:343-50,
22. Cars O, Molstd S, Melander A. Variations in antibiotic use in the European Union. Lancet 2001;357:1851-3.
23. Voss A, Milatovic D, Wallrauch-Schwartz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Europ J Clin Microbiol Infect Dis 1994;13:50-5.
24. Hanberger H, Garcia-Rodrigues JA, Gobernado M, Goossens H, Nielsson LE, Struelens MJ, et al. Antibiotic susceptibility among aerobic Gram-negative bacilli in Intensive Care Units in 5 European Countries. JAMA 1999;281:67-71.
25. Gould IM. A review of the rules of antibiotic policies in the control of antibiotic resistances. J Antimicrob Chemotherapy 1999;43:459-65.
26. Oethinger M, Conrad S, Kaifel K, Cometta A, Bille J, Klotz G, et al. Molecular epidemiology of fluoroquinolone-resistant E. Coli bloodstream isolates from patients admitted to European Centers. Antimicrob Ag Chemotherapy 1996;40:287-92.
27. Cometta A, Calandra T, Bille J, Glauser MPE. Coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 1994;330:1240-1.
28. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999;341:233-9.
29. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patients outcome in the ICU setting. Chest 2000;118:146-55.
30. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.
31. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteraemia. Clin Infect Dis 1999;29:60-6.
32. Gertman PM, Restuccia JD. The approprieness Evaluation Protocol: a technique for assessing unnecessary days or hospital care. Medical Care 1981;8:855-69.
33. Damoiseaux RA, de Melker RA, Ausems MJ, Van Balen FA. Reasons for non-guidelines based antibiotic prescriptions for acute otitis media in the Netherlands. Family Practices 1999;16(1.2):50-3.
34. Poses RM, Cebul RD, Wrigton RS. You can't lead a hole to water - improving physicians' knowledge of probabilities may not affect their decisions. Med Decision Making 1995;15(1):65-75.
35. De Sutter AI, de Meyer MJ, de Maeseneer JM, Peersam WP. Antibiotic prescribing in acute infections of the nose or sinuses: a matter of personal habit? Family Practice 2001;18(2):209-13.
36. Hummer-Pradier E, Dening P, OCoke T, Lagerlov P, Wahlstroem R, Haaijer-Ruskamp M, et al. GPs' treatment of uncomplicated urinary tract infection - clinical judgement analysis in four European Countries. Family Practices 1999;16(6):605-7.
37. e Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse, 1998 Livre des abstracts 212/C18161.